# Molecular Endotypes of Chronic Idiopathic Urticaria

> **NCT04774315** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 15 (estimated)

## Conditions studied

- Chronic Urticaria, Idiopathic

## Interventions

- **DRUG:** Omalizumab

## Key facts

- **NCT ID:** NCT04774315
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-01-01
- **Primary completion:** 2025-03
- **Final completion:** 2025-03
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04774315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04774315, "Molecular Endotypes of Chronic Idiopathic Urticaria". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04774315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*